the cost of a human phase 3 clinical trial varies quite a lot depending on the length of the trial and the amount of participants. I would be very surprised if any of ihls phase 3 trials cost more than $30million to be honest and im confident most if not all trials will actually succeed. Granted the success rate for phase 3 is quite low however the anecdotal and clinical evidence on all fronts that ihl is pursuing is pointing to success. We shall see but i remain very confident.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL appoints EAS Advisors LLC to facilitate US listing
Ann: IHL appoints EAS Advisors LLC to facilitate US listing, page-141
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online